Stocks · News reference
Autoliv Is Advancing The Development Of Virtual Testing Through Its Human Body Model Safety Suite
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RBC Capital Maintains Outperform on Autoliv, Lowers Price Target to $147
RBC Capital analyst Tom Narayan maintains Autoliv (NYSE:ALV) with a Outperform and lowers the price target from $148 to $147.
TD Cowen Maintains Buy on Autoliv, Lowers Price Target to $148
TD Cowen analyst Itay Michaeli maintains Autoliv (NYSE:ALV) with a Buy and lowers the price target from $150 to $148.